首页> 外文期刊>Терапевтичесκий архив >New approaches to treatment of bradyarrhythmia in patients with obstructive sleep apnea syndrome
【24h】

New approaches to treatment of bradyarrhythmia in patients with obstructive sleep apnea syndrome

机译:阻塞性睡眠呼吸暂停综合征患者心律失常的新治疗方法

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To confirm or reject effects of CPAP on sleep asystole and to elucidate possible dependence on correction of respiratory disorders. MATERIAL AND METHODS: Thirteen patients (11 males and 2 females aged 19 to 66 years) with bradyarrhythmia (BA) arising in sleep participated in the study. BA was caused by transient atrioventricular block of the degree II-III in 9 cases (69%), episodes of sinus node arrest and/or synoatrial block in 6 (46%) cases. Two (15%) patients had combination of BA forms. To diagnose sleep respiratory disorders, polysomnography (PSG) was made. Diagnostic criteria of sleep obstructive apnea syndrome (SOAS) were apnea/hypopnea index (AHI) more than 5 episodes for 1 hour sleep. The patients were divided into two groups. Individual selection of therapeutic pressure under PSG control was performed in SOAS patients (the study group). CPAP-therapy was effective in AHI < 5. In the control group (AHI < 5) such selection was made too. CPAP-therapy was effective in the controls if episodesof apnea/hypopnea were not registered through the night of monitoring. RESULTS: In the study group CPAP-therapy was effective. The AHI decreased from 73.2 to 4.4, oxygen saturation of arterial blood increased from 74 to 85%, mean duration of asystoles fell from 5.2 to 1.3 s, pauses with duration more than 2 s disappeared. In the control group sleep apnea/hypopnea episodes disappeared but in asystole CPAP was uneffective. CONCLUSION: CPAP-therapy is effective and pathogenetically sound method of treating patients with nocturnal bradyarrhythmia associated with sleep respiratory disorders.
机译:目的:确认或拒绝CPAP对睡眠心搏停止的影响,并阐明对呼吸系统疾病纠正的可能依赖。材料与方法:十三名睡眠中出现心律失常的患者(男11例,女19至66岁,女2例)参加了该研究。 BA由9例(69%)的II-III度短暂房室传导阻滞,6例(46%)的窦房结阻滞和/或窦房阻滞引起。 2名(15%)患者合并了BA形式。为了诊断睡眠呼吸系统疾病,进行了多导睡眠监测(PSG)。睡眠障碍性呼吸暂停综合症(SOAS)的诊断标准为1小时睡眠超过5次以上的呼吸暂停/呼吸不足指数(AHI)。将患者分为两组。在SOAS患者(研究组)中,在PSG控制下对治疗压力进行个体选择。 CPAP治疗对AHI <5有效。在对照组(AHI <5)中也进行了这种选择。如果在整个监测晚上未发现呼吸暂停/呼吸不足发作,则CPAP治疗对对照组有效。结果:在研究组中,CPAP疗法是有效的。 AHI从73.2降低到4.4,动脉血氧饱和度从74增加到85%,平均停搏持续时间从5.2降低到1.3 s,暂停时间超过2 s消失了。在对照组中,睡眠呼吸暂停/呼吸不足发作消失,但在心搏停止时,CPAP无效。结论:CPAP疗法是一种有效的,在病原学上合理的方法,可治疗伴有睡眠呼吸系统疾病的夜间缓慢性心律失常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号